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Background: Early HIV-1 infection causes massive CD4+ T cell death in the gut and translocation of bacteria into the
circulation. However, the programmed cell death (PCD) pathways used by HIV-1 to kill CD4+ T cells in the gut, and
the impact of microbial exposure on T cell loss, remain unclear. Understanding mucosal HIV-1 triggered PCD could
be advanced by an ex vivo system involving lamina propria mononuclear cells (LPMCs). We therefore modeled the
interactions of gut LPMCs, CCR5-tropic HIV-1 and a commensal gut bacterial species, Escherichia coli. In this Lamina
Propria Aggregate Culture (LPAC) model, LPMCs were infected with HIV-1BaL by spinoculation and cultured in the
presence or absence of heat killed E.coli. CD4+ T cell numbers derived from flow cytometry and viable cell counts
were reported relative to mock infection. Viable cells were identified by viability dye exclusion (AqVi), and intracellular
HIV-1 Gag p24 protein was used to identify infected cells. Annexin V and AqVi were used to identify apoptotic versus
necrotic cells. Caspase-1 and Caspase-3 activities were blocked using specific inhibitors YVAD and DEVD, respectively.
Results: CD4+ T cell depletion following HIV-1 infection was reproducibly observed by 6 days post infection (dpi).
Depletion at 6 dpi strongly correlated with infection frequency at 4 dpi, was significantly blocked by Efavirenz
treatment, and was primarily driven by p24-negative cells that were predominantly necrotic. HIV-1 infection
significantly induced CD4+ T-cell intrinsic Caspase-1 activity, whereas Caspase-1 inhibition, but not Caspase-3
inhibition, significantly blocked CD4+ T cell depletion. Exposure to E.coli enhanced HIV-1 infection and CD4+ T
depletion, and significantly increased the number of apoptotic p24+ cells. Notably, CD4+ T cell depletion in the
presence of E.coli was partially blocked by Caspase-3, but not by Caspase-1 inhibition.
Conclusions: In the LPAC model, HIV-1 induced Caspase-1 mediated pyroptosis in bystander CD4+ T cells, but
microbial exposure shifted the PCD mechanism toward apoptosis of productively infected T cells. These results
suggest that mucosal CD4+ T cell death pathways may be altered in HIV-infected individuals after gut barrier
function is compromised, with potential consequences for mucosal inflammation, viral dissemination and systemic
immune activation.
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HIV-1 infection is characterized by high levels of virus
replication, gradual peripheral CD4+ T cell depletion,
and aberrantly high immune activation. Chronic immune
activation may result from pathogenic events in the gut
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stated.replication in the intestinal mucosa results in massive kill-
ing of lamina propria (LP) CD4+ T cells, enteropathy, in-
flammation, and microbial translocation [1,2]. However,
the mechanisms and pathways involved in HIV-associated
LP CD4+ T cell depletion remain key unanswered ques-
tions in basic HIV research [3,4].
Major efforts to investigate the mechanisms of HIV-1
mediated CD4+ T cell depletion have been made using
ex vivo models of HIV-1 infection in primary human
CD4+ T cells or cell lines. Ex vivo modeling studies of
HIV-1 infection of primary human CD4+ T cells indi-
cated that HIV-1-mediated killing could occur in bothtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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infected, cells. CXCR4-tropic (X4) HIV-1 was found to
kill resting spleen and tonsil CD4+ T cells ex vivo through
abortive infection [5], whereas double-stranded DNA
breaks occurring during HIV-1 integration were respon-
sible for the death of productively-infected CD4+ T cells
from peripheral blood [6]. However, it remains unclear
whether the death of productively-infected or bystander
cells is primarily responsible for driving human LP CD4+
T cell depletion. Interestingly, earlier studies in the SIV/
rhesus macaque model also suggested that LP CD4+ T cell
death could occur in both productively infected [7] and
bystander [8] cells to drive depletion. Unraveling the
mechanisms underlying HIV-1 mediated LP CD4+ T
cell depletion may require the use of primary human LP
CD4+ T cell lymphocytes.
Unlike peripheral blood or lymphoid CD4+ T cells, LP
CD4+ T cells are predominantly of a recently activated,
CCR5hi effector memory phenotype [9]. These cells are
highly susceptible to infection by CCR5-tropic HIV-1
strains, which are found in over 90% of chronically HIV-
infected patients, and account for most transmitted viruses
[10,11]. The LP CD4+ T cell pool in the gut-associated
lymphoid tissue (GALT) is a heterogeneous population
comprised of multiple T helper (Th) subsets that have di-
verse functions in host defense [12]. In particular, the loss
of mucosal IL-17 producing T cells (Th17), which play a
role in defense against extracellular pathogens, has been
closely linked to pathogenic SIV and HIV infection [13-15].
The gut microbiome also plays an important role in
establishing the LP microenvironment. In HIV-1 infection,
translocation of microbial products strongly correlates with
increased immune activation [16-18]. In fact, commensal
Gram-negative Escherichia coli (E.coli) was detected in
the LP of rhesus macaques during early stages of patho-
genic SIV infection [19]. Thus, adequately modeling
HIV interactions in the LP must account for any effects
of commensal bacteria. We previously showed that
commensal E.coli activates resident LP CD4+ T cells in
an MHC Class II-dependent fashion [20], and increases
HIV-1 replication in human LP CD4+ T cells ex vivo
[21]. However, the impact of microbial exposure on the
magnitude and mechanisms of LP CD4+ T cell death re-
mains unknown.
To date, very limited information exists as to which
cell death pathway(s) are triggered in human LP CD4+
T cells by R5-tropic HIV-1 infection. Most programmed
cell death (PCD) pathways are dependent on proteolytic
enzymes known as caspases. In the canonical PCD path-
way, apoptosis, cells undergo cell shrinkage, blebbing
and DNA fragmentation but retain plasma membrane
integrity [22]. Apoptosis can be triggered by either ex-
trinsic (e.g. Fas/FasL) or intrinsic stimuli, but both path-
ways converge on the effector molecule Caspase-3 [23].Apoptotic cells are generally disposed of in vivo in a non-
inflammatory manner through the exposure of phosphoti-
dylserine (PS) from the inner leaflet of the plasma mem-
brane to the cell surface [24-26]. There is a substantial
body of literature suggesting that apoptosis is aberrantly
triggered or has become dysregulated during HIV-1 infec-
tion [27-29]. In contrast to apoptosis, pyroptosis is a highly
inflammatory form of PCD that involves oncosis, plasma
membrane rupture, and the rapid release of cytoplasmic
contents into the surrounding environment [22,30]. Pyrop-
tosis has been linked to the ‘inflammasome’, a multimeric
complex containing active Caspase-1 and pattern recogni-
tion receptors such as NLRP3 [30,31]. In addition to medi-
ating pyroptosis, Caspase-1 processes pro-IL-1β to the
mature secreted form that could contribute to inflamma-
tion and epithelial barrier dysfunction [32,33]. Interestingly,
increased Caspase-1 activity has been documented in HIV
infection ex vivo in the Human Lymphoid Aggregate Cul-
ture (HLAC) model and in primary peripheral blood T
cells from HIV infected patients [5,34,35]. It remains un-
known whether Caspase-1 plays a role in HIV-1 mediated
LP CD4+ T cell death.
In this report, we used the Lamina Propria Aggregate
Culture (LPAC) model to identify the PCD pathway(s)
triggered in primary LP CD4+ T cells ex vivo by infec-
tion with an R5 tropic HIV-1 strain. We further assessed
the impact of commensal E. coli exposure on the magni-
tude and mechanisms of HIV-mediated LP CD4+ T cell
depletion. We provide evidence for augmented HIV-1
mediated LP CD4+ T cell death and a shift in the PCD
pathway following microbial exposure.
Results
CD4+ T cell depletion strongly correlates with productive
infection in the LPAC model
To monitor HIV-1 mediated LP CD4+ T cell death, we
utilized primary LP mononuclear cells (LPMC) in an ex-
perimental strategy which involved quantifying absolute
LP CD4+ T cell numbers in HIV-1-infected relative to
mock infected cultures [5]. Given the similarities of our ex-
perimental approach to that of the HLAC model, we refer
to this infection platform as the ‘Lamina Propria Aggregate
Culture’ or LPAC model. LPMCs were infected with R5-
tropic HIV-1Ba-L by spinoculation and analyzed at the indi-
cated days post-infection (dpi) (Figure 1A). Since HIV-1
downregulates surface CD4 expression in vitro [36], CD4+
T cells were identified as CD3+CD8-. Viable CD3+CD8-
T cells were identified using the gating strategy shown
(Figure 1B). At 4 dpi, the absolute numbers of CD4+ T
cells in mock infected and HIV-infected wells were not sig-
nificantly different (Figure 1C left panel). However, by 6
dpi, HIV-1-infected wells had significantly fewer CD4+ T
cells than mock (Figure 1C right panel). To compare the
extent of HIV-1-mediated depletion between donors, the
Figure 1 HIV-1 mediated cell death can be quantified in the LPAC model. (A) Lamina Propria Aggregate Culture (LPAC) model. Primary
LPMCs from discarded surgical samples were infected with CCR5-tropic HIV-1Ba-L (80 ng p24 per 1 M LPMC), cultured for 1–6 days and harvested
for flow cytometry. (B) Representative gating strategy. (C) The absolute number of CD4+ T cells per well in mock or HIV-1 infected conditions.
N = 17 donors. Each symbol is a unique donor. Significant differences at each time point was determined by Wilcoxon matched pairs signed rank
test. (D) To compare relative depletion between donors, CD4+ T cell survival was normalized to mock infection (100% survival). Each symbol is an
individual donor. Horizontal solid lines reflect the median. Significance was determined using the Kruskal-Wallis test across timepoints. (E) Cell-
specificity of HIV-1 mediated depletion in the LPAC model. The percent survival relative to mock infection at 6 dpi was determined for CD3+CD8- T
cells (white), CD3+CD8+ T cells (light grey), and CD3-CD19+ B cells (dark grey). The black bar depicts 100% survival for each cell type in the mock infected
condition, also indicated by the dashed horizontal line. Significance was determined using the Kruskal-Wallis test and Dunn’s multiple comparison test to
compare selected pairs of columns. **p= 0.0015; ***p= 0.0003; ****p< 0.0001.
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(100% survival). Depletion was not statistically significant
overall at 4 dpi, but about half (9 of 17) of the samples ex-
hibited some level of depletion (‘depleters’; Figure 1D). De-
pletion was significantly greater at 6 dpi than at 4 dpi
(Figure 1D). CD3+CD8+ T cells and CD3-CD19+ B cells
were not depleted relative to mock infection (Figure 1E).
Thus, LP CD4+ T cell depletion can be specifically and re-
liably quantified in the LPAC model by 6 dpi.
We then assessed the relationship between productive
HIV-1 infection and LP CD4+ T cell depletion. Productive
HIV-1 infection was measured using intracellular HIV-1
Gag-p24 (p24) expression. Positive p24 expression was
established from the mock infected control (<1% p24+)
(Figure 2A). The frequency of CD3+CD8-p24+ cells at 4
dpi strongly correlated with LP CD4+ T cell depletion at 6
dpi in HIV-infected cultures (Figure 2B). In addition, the
percentage of p24+ cells was 2.3-fold greater in the 9 ‘de-
pleter’ samples (Figure 1D) than the 8 ‘non-depleter’samples (Figure 2C) despite similar cellular LPMC com-
position prior to infection (Additional file 1: Figure S1).
To confirm that depletion was dependent on productive
HIV-1 infection, early reverse transcription was inhibited
using the antiretroviral drug, Efavirenz. Efavirenz at 1 nM
or 10 nM blocked p24 expression and T cell depletion in a
dose dependent fashion (Figure 2D). The 10 nM Efavirenz
dose was sufficient to significantly decrease p24 expres-
sion and increase the survival of CD3+CD8- T cells rela-
tive to untreated HIV infection (Figure 2E). These results
indicate that in the LPAC model, active HIV-1 replication
is required for LP CD4+ T cell depletion.
HIV-1 infection increases the frequency of CD4 T cells
with apoptotic and necrotic phenotypes
To address potential mechanisms of HIV-1-mediated
LP CD4+ T cell death, we profiled the CD4+ T cells ei-
ther as early apoptotic (AnnexinV+AqVi-) or necrotic
(AnnexinV+AqVi+) by flow cytometry (Figure 3A).
Figure 2 Relationship between HIV-1 infection and LP CD4+ T cell depletion. (A) Representative flow plots identifying p24+ cells using the
gate established in mock infection (<1%). The net frequency of p24+CD4+ T cells (e.g.,%p24+ =%p24+ in HIV-1 minus %p24+ in Mock) is
reported. (B) Spearman rank correlation analysis between the percentage of p24+ cells at 4 dpi and the level of LP CD4+ T cell depletion at 6
dpi. The best-fit line, Spearman r and the p value are indicated. (C) The percentage of p24+ cells was compared between ‘depleters’ and
‘non-depleters.’ Each point is a unique sample. The horizontal solid line indicates the median infection level. Statistical significance was deter-
mined by Mann–Whitney U test, *p = 0.03. (D-E) LPMCs were pre-treated with Efavirenz for 2 h prior to infection with HIV-1Ba-L or mock and re-
dosed at 3 dpi. The net frequencies of p24+ cells (overall ANOVA p = 0.0008) were calculated for each donor at 6 dpi (Figure 2D). The percentage
of CD4+ T cells surviving relative to mock infection in the presence of Efavirenz is shown (overall ANOVA p = 0.0394) (Figure 2E). The medians are
shown and the dashed horizontal line indicates 100% survival relative to mock infection. Statistically significant differences were determined using
the Friedman Test and Dunn’s Multiple Comparison test to compare between groups.
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ceeded to secondary necrosis, pyroptosis, and necroptosis,
converge on the necrotic phenotype given sufficient time
[24,25,37]. Cell death profiles were measured at 4 dpi
when early apoptotic cells were detectable. HIV-1 infec-
tion increased the percentage of CD4+ T cells expressing
both apoptotic and necrotic phenotypes relative to mock
(Figure 3B).
We next compared the p24+ and p24neg populations
to gain insight into their respective contributions to total
CD4+ T cell loss. The percentage of cells with an apoptotic
phenotype was greater in the p24+ population, whereas the
percentage of cells with a necrotic phenotype was greaterin p24neg population (Additional file 2: Figure S2A). How-
ever, since there were more p24neg cells than p24+ cells in
the culture, the absolute numbers of apoptotic p24+ and
p24neg cells were similar at 4 dpi (Figure 3C), suggesting
that apoptosis contributed equally to depletion in both
subsets. In sharp contrast, the absolute number of p24neg
cells with a necrotic phenotype was 34-fold greater than
the number of necrotic p24+ cells (Figure 3C). Presented
another way, 63% of the CD4+ T cells committed to dying
(AnnexinV+) were p24neg and had a necrotic phenotype
(Figure 3D), indicating that necrotic cell death in the
p24neg population accounted for the majority of depletion
during HIV-1 infection. The p24+ cells accounted for only
Figure 3 HIV-1 infection increases cell death markers in LP CD4+ T cells. (A) Representative flow plot of AnnexinV/AqVi staining. Note that
in contrast to Figure 1B, there was no AqVi exclusion gate prior to identifying lymphocytes from the FSC/SSC profile. Cells expressing AnnexinV
were considered committed to dying. (B) The percentage of CD3+CD8- T cells expressing either an apoptotic (left) or necrotic (right) profiles
were compared between mock and HIV-1 infected conditions. Each symbol is a unique donor. The fold differences in median expression are
shown. Significance was determined using the Wilcoxon matched-pairs signed rank test. (C) The numbers of p24+ and p24neg cells per well with
an apoptotic or necrotic phenotype were calculated. Each symbol represents a unique donor. The median values are shown and the fold-change
is indicated for significant differences. Significance was determined using the Wilcoxon matched-pairs signed rank test. (D) Apoptotic versus
necrotic p24+ and p24neg cells as a percentage of the total number of LP CD3+CD8- T cells committed to death (n = 11). (E-F) Spearman rank
correlation analysis between the number of AnnexinV+ (E) p24neg and (F) p24+ cells 4 dpi versus the 6 dpi depletion levels. The best-fit lines,
Spearman r and p values are indicated. **, p = 0.009; ***, p = 0.001.
Steele et al. Retrovirology 2014, 11:14 Page 5 of 14
http://www.retrovirology.com/content/11/1/1413% of the total dying cells (Figure 3D), but it was the
magnitude of p24+ cell death that correlated with HIV-1
mediated LP CD4+ T cell depletion measured at 6 dpi
(compare Figure 3E and F).
HIV-1 promotes LP CD4+ T cell death predominantly
through Caspase-1-mediated pyroptosis
We next considered non-apoptotic PCD pathways that
could lead to a necrotic phenotype. Pyroptosis is a
Caspase-1-dependent PCD pathway that was recently
implicated in HIV-1-mediated death of resting lymphoid
T cells [5]. Caspase-1 activity was measured by flow cy-
tometry in mock or HIV-infected LPMCs at 2 and 6 dpi
using a fluorogenic Caspase-1 substrate (CaspaLux-1).
CD3+CD8- T cells with active Caspase-1 were identified
from a tight lymphocyte gate (Figure 4A-B). Caspase-1
activity was significantly induced in LP CD4+ T cells in
HIV-infected cultures compared to mock by 6 dpi(Figure 4C). These findings provide evidence for LP
CD4+ T cell intrinsic Caspase-1 activity that occurred
concurrent with depletion.
Irreversible peptide inhibitors were used to block the
function of Caspase-1 (pyroptosis; YVAD) and Caspase-3
(apoptosis; DEVD) to determine their relative effects on
HIV-1 induced depletion. To avoid toxicity, we used the
highest possible dose (25 μM) of each inhibitor at a non-
toxic DMSO concentration and added each inhibitor
(25 μM) at days 0 and 2 (Figure 1A). Depletion was deter-
mined relative to mock infection and normalized to the
DMSO vehicle control (100% depletion) to determine the
percent protection from depletion with each inhibitor for
each donor (Figure 4D; representative donor). Neither
DEVD nor YVAD significantly altered the frequency of
p24+ CD4+ T cells compared to the DMSO control, indi-
cating that HIV-1 replication was not impeded by the
presence of drug (Additional file 3: Figure S3A). In 6
Figure 4 HIV-1 induced T cell Caspase-1 activity and death in non-productively infected LP CD4+ T cells. (A) Detection of active Caspase-1
in T cells. At 2 and 6 dpi, LPMCs were harvested and incubated for 30 min with the CaspaLux-1 Substrate (Oncoimmunin) then surface stained to
allow for identification of CD3+CD8- T cells by flow cytometry. Cells were gated from a tight lymphocyte gate that excluded cellular debris. Cleaved
CaspaLux-1-E1D2 was detected in CD3+CD8- T cells using the FITC channel. (B) Representative histograms of Caspalux-1-E1D2 staining. (C) HIV-1
induced Caspase-1 activity in LP CD4+ T cells. The fold change in median Caspase-1 activity is shown at 6 dpi. Significance was determined using the
Wilcoxon matched-pairs signed rank test. (D). YVAD (Caspase-1; 25 μM), DEVD (Caspase-3; 25 μM) or a DMSO vehicle control were added at 0 and 2
dpi and CD4+ T cell survival was evaluated at 4 dpi. LP CD4+ T cell survival was normalized to parallel mock infections. The number of cells per well in
a representative donor with mock (white bar) or HIV-1 (grey bar) infection with DMSO (left), DEVD (center) and YVAD (right). The percent depletion from
mock are indicated for each condition. (E) The percent depletion from mock infected controls are shown in the presence of DMSO (white box), DEVD
(light grey), and YVAD (dark grey) (n = 6). Box and whiskers indicate the median and range respectively. Significant differences in the percent depletion
from the DMSO vehicle were determined using non-parametric repeated measures ANOVA. Dunn’s multiple comparison tests were used to compare
selected pairs of columns as shown. Overall ANOVA, p = 0.0003. *p = 0.02–0.03.
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cells by 4 dpi relative to mock infection with DMSO
(Figure 4E). DEVD did not significantly inhibit LP
CD4+ T cell depletion (Figure 4E). However, YVAD sig-
nificantly attenuated HIV-1 mediated depletion from
36% to 18% (Figure 4E) indicating a role for Caspase-1
activity in HIV-1 mediated LP CD4+ T cell death.Exposure to commensal E. coli alters the kinetics and
increases the magnitude of HIV-1 mediated LP CD4+ T
cell depletion in the LPAC model
We previously reported that commensal E. coli exposure
augmented HIV-1 infection of LPMCs [21], but the impact
of E. coli exposure on LP CD4+ T cell death remained un-
known. As expected, E. coli exposure in the LPAC model
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number (data not shown) of p24+ cells at 4 dpi and 6
dpi relative to HIV-1 infection only. Importantly, LP
CD4+ T cell depletion was also significantly enhanced at
both 4 dpi (Figure 5B left panel) and 6 dpi (Figure 5B
right panel) in the presence of E. coli. This contrasts
with the kinetics of depletion in the HIV-1 infection
without E. coli condition, when reproducible depletion
was not observed until 6 dpi (Figure 1D). Of note, no
depletion was observed in CD3+CD8+ or CD3-CD19+
cells in the presence of E. coli (Figure 5C), indicating
that the enhanced depletion was specific to CD4+ T
cells and not due to potential non-specific cell death
from direct microbial activation. In summary, exposure
to commensal E. coli increased the magnitude and kin-
etics of LP CD4+ T cell depletion in the LPAC model.Figure 5 Commensal E. coli enhance apoptosis in productively infecte
productively infected cells. The percentage of p24+ cells in the presence o
expression. Significance was determined using the Wilcoxon matched-pairs
presence of absence of E. coli normalized to mock (100% survival). Significa
the Wilcoxon matched-pairs signed rank test. (C) Cell-specificity of HIV-1 m
mock infection at 6 dpi was determined for CD3+CD8- T cells (white), CD3
black bar depicts 100% survival for each cell type in the mock infected con
determined using the Kruskal-Wallis test and Dunn’s multiple comparison t
was determined following stimulation with PMA/Ionomycin. Viable cell cou
percentage of CD3+CD8- T cells expressing cytokine. Survival was determin
indicate the median and range respectively. Significant differences in cell s
matched-pairs signed rank test. (E) Spearman rank correlation analysis betw
cell depletion at 6 dpi. The best-fit line, Spearman r and the p value are indPathogenic lentivirus infection is associated with exten-
sive depletion of the gut Th17 subset which plays a key
role in bacterial defense [13,14,38-40], raising the possibil-
ity that the Th subsets in the LP may have different
susceptibilities to HIV-1 mediated killing. We therefore
investigated the susceptibility of Th1 (IFN-γ+IL-17-),
Th17 (IL-17+IFN-γ-), Th1/17 (IFN-γ+ IL-17+) and non-
Th1/17 (IFN-γ-IL-17-, double negative, DN) subsets to
undergo HIV-1 mediated death at 6 dpi in the presence or
absence of bacteria. The Th subsets were identified by
intracellular cytokine staining by flow cytometry following
PMA/Ionomycin stimulation. At 6 dpi, R5-tropic HIV-1
depleted Th1, Th17 and Th1/17 cells in the LPAC model
to a similar extent (Figure 5D). In contrast, DN cells were
relatively resistant to HIV-1 mediated killing (Figure 5D).
Commensal E. coli exposure led to 2 to 3-fold increasedd LP CD4+ T cells. (A) Commensal E. coli increases the frequency of
f a 5:1 E. coli: LPMC ratio was quantified using intracellular p24
signed rank test. (B) LP CD4+ T cell survival was compared in the
nt differences in cell survival at 4 dpi or 6 dpi were determined using
ediated depletion in the LPAC model. The percent survival relative to
+CD8+ T cells (light grey), and CD3-CD19+ B cells (dark grey). The
dition, also indicated by the dashed horizontal line. Significance was
ests to compare selected pairs of columns. (D) Th Subset survival
nts were obtained prior to PMA/Ionomycin and multipled by the
ed normalized to mock infection for all subsets. Box and whiskers
urvival for each subset were determined using the Wilcoxon
een the percentage of p24+ cells at 4 dpi and the level of LP CD4+ T
icated. *p = <0.05; ***p = 0.0005; ****p < 0.0001.
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compared to HIV-1 alone (Figure 5D). Remarkably, E. coli
enhanced depletion in the Th1/17 depletion by 10-fold
(Figure 5D). As with HIV-1 infection alone (Figure 2B),
the level of productive infection was strongly associated
with the level of depletion following E. coli exposure
(Figure 5E; Spearman r for samples with E.coli = 0.5760;
p = 0.017).
Exposure to E. coli increases the death of productively
infected cells through increased apoptosis
Since E. coli exposure increased the number of p24+
cells and overall depletion, we assessed the proportion of
cells with an early apoptotic or necrotic phenotype in the
p24+ and p24neg populations (Figure 3A) in the presence
of E. coli. As with HIV-1 infection alone, p24+ cells
remained more likely to have an apoptotic phenotype thanFigure 6 E. coli alters caspase-dependent LP CD4+ T cell death. (A an
in the LPAC model. The absolute numbers of p24+ cells that were either a
p24+ and (B) p24neg cells. Each symbol represents a unique donor. Signific
test within each phenotype. (C) Apoptotic versus necrotic p24+ or p24neg
death (n = 11). Compare to Figure 4B. (D) Impact of E.coli on cell death ma
mock-infected cells were compared with or without E.coli. The horizontal li
marker expression. Significance was determined using the Wilcoxon match
depletion from mock infection in the presence of YVAD and DEVD (n = 7) a
p = 0.008. *p = < 0.05 **, p = 0.007; ***, p = 0.001.p24neg cells, whereas p24neg cells remained more likely to
have a necrotic profile than p24+ cells (Additional file 2:
Figure S2B). Notably, the absolute number of p24+ cells
with both apoptotic and necrotic phenotypes increased
significantly in the presence of E. coli compared to HIV-1
alone (Figure 6A). In contrast, E. coli had no effect on the
absolute number of p24neg cells with either an apoptotic
or necrotic phenotype (Figure 6B). In total, p24+ cells
accounted for 39% of the CD4+ T cell death in the pres-
ence of E. coli (Figure 6C), in sharp contrast to HIV-1
infection only (Figure 3D). Importantly, the majority of
the p24+ CD4+ T cells were apoptotic in the presence
of E. coli. The addition of E. coli significantly increased
the percentage of cells with an apoptotic phenotype by
1.5-fold in mock infected cells (Figure 6D) but did not
alter the percentage of cells with a necrotic phenotype
(Figure 6D). Thus, increased HIV-1 mediated LP CD4+ Td B) Impact of E.coli exposure on apoptotic and necrotic phenotypes
poptotic (left) or necrotic (right) were determined as in Figure 3 for (A)
ance was determined using the Wilcoxon matched-pairs signed rank
cells as a percentage of the total LP CD3+CD8- T cells committed to
rkers in uninfected LPMCs. The percentage of apoptotic or necrotic
nes indicate the median values and the fold-differences in cell death
ed-pairs signed rank test within each phenotype. (E) The percent
s described in Figure 5 in the presence of E.coli. Overall ANOVA,
Steele et al. Retrovirology 2014, 11:14 Page 9 of 14
http://www.retrovirology.com/content/11/1/14cell apoptosis in the presence of E.coli likely reflects both
virus- and bacteria-induced cell death.
DEVD and YVAD were used to determine whether
Caspase inhibition could block HIV-1 associated LP
CD4+ T cell death in the presence of E. coli. The inhibi-
tors did not significantly decrease the LP CD4+ T cell
number in the mock plus E. coli condition (Additional
file 3: Figure S3C-D). LP CD4+ T cell depletion in the
presence of HIV-1 plus E. coli was significantly blocked
by DEVD compared to the DMSO control (Figure 6E).
Surprisingly, Caspase-1 inhibition by YVAD did not sig-
nificantly prevent LP CD4+ T cell depletion with virus
and E. coli present (Figure 6E). The results suggest that
in the presence of E.coli, HIV-1 mediated LP CD4+ T
cell death is Caspase-3, but not Caspase-1, dependent.
Discussion
Counteracting inflammation and immune activation in
HIV-1 infection may require resolving critical knowledge
gaps about how HIV-1 causes extensive LP CD4+ T cell
death during primary infection. Here, we demonstrate
the versatility of the LPAC model in addressing these
critical questions regarding the mechanisms underlying
R5-tropic HIV-1 mediated mucosal CD4+ T cell death.
We provide evidence that HIV-1 induces pyroptosis of
non-productively infected LP CD4+ T cells based on the
detection of active Caspase-1 in CD4+ T cells and the
inhibition of LP CD4+ T cell depletion by blocking
Caspase-1 activity. Surprisingly, our results with primar-
ily effector memory LP CD4+ T cells mirrored published
findings based on X4-tropic HIV-1 infection of HLAC
cells [5], which are predominantly resting CD4+ T cells.
Thus, despite the important differences in CD4+ T cell
phenotypes between the two ex vivo models, pyroptosis
appears to be a critical HIV-1-induced PCD pathway in
non-productively infected CD4+ T cells.
The molecular trigger(s) for Caspase-1 mediated death in
the LPAC model remain unknown, but recent high-profile
studies suggest plausible mechanisms [5,6,41,42]. One pos-
sibility is that the accumulation of incomplete HIV-1 re-
verse transcripts in abortively infected LP CD4+ T cells
triggered death, analogous to that reported in the HLAC
model [5]. In this model, IFI16 has been identified as the
DNA sensor that triggers pyroptosis in the bystander T
cells [42], and p24+ cells were shown to be the killing unit
rather than the free virus [5]. Notably, in the LPAC model,
it was the number of dying p24+, but not p24neg cells,
which significantly correlated with depletion. If a similar
PCD mechanism operates in the LPAC as in the HLAC
model, each p24+ cell could induce cell death in variable
number of bystander cells, thereby weakening the associ-
ation between p24neg cells and depletion. However, LP
CD4+ T cells are more susceptible to HIV-1 infection than
resting HLAC CD4+ T cells due to higher activation levelsand expression of HIV-1 co-receptors [9,43]. Thus, at this
time, we cannot confirm that abortive infection triggers
pyroptosis in the gut and cannot exclude alternative
triggers for Caspase-1 activity. Nabel and colleagues re-
cently reported decreased HIV-1 gene expression fol-
lowing DNA-PK recognition of double-stranded DNA
breaks during integration [6]. Thus, an alternative hy-
pothesis is that HIV-1 gene expression is being quickly
shut off in permissive LP CD4+ T cells upon integration
induced cell death, and permissive cells dying post-HIV-
1 integration could appear as p24neg. Loss of viral pro-
tein expression in permissive cells could also potentially
explain the strong association we observed between the
frequency of productively infected cells and depletion.
However, to our knowledge, there is no established link
between DNA-PK and Caspase-1 activities.
Caspase-1 activity may be a potential link between
HIV-1-mediated LP CD4+ T cell death and HIV-1-
mediated mucosal inflammation. In antigen presenting
cells, Caspase-1 cleaves pro-IL-18 and pro-IL-1β to their
active forms [30]. Increased IL-1β expression was ob-
served in the LP during acute pathogenic SIV, but not dur-
ing non-pathogenic infection, suggesting that Caspase-1
activity could be a mediator of lentivirus pathogenesis
[38]. IL-1β, other pro-inflammatory cytokines, and HIV-1
gp120 have been shown to cause tight junction breakdown
between intestinal epithelial cells in vitro [32,44]. Further-
more, pyroptosis releases cellular contents into the envir-
onment that can act as danger-associated molecular
patterns (DAMPs), thereby triggering inflammation in the
local microenvironment [30,31]. Thus, Caspase-1 activity
in LP CD4+ T cells could precipitate epithelial barrier dys-
function by releasing either traditional inflammatory cyto-
kines or cellular DAMPs.
Epithelial barrier breakdown results in microbial trans-
location during the later stages of acute SIV infection [19],
suggesting that studies in the LPAC model are incomplete
without taking enteric bacteria into account. We previ-
ously reported [21] that exposure to commensal bacteria
increased productive infection in LP CD4+ T cells in vitro,
likely by enhancing T cell activation. We now link these
findings to increased LP CD4+ T cell depletion in the
presence of commensal bacteria. In addition, the LPAC
data for Th subsets recapitulated the high susceptibility of
IL-17-producing cells to HIV-1-mediated depletion ob-
served in vivo and highlighted a role for microbial expos-
ure in exacerbating this process [13,14,38-40].
Exposure to E. coli increased overall LP CD4 T cell
depletion by increasing the number of productively in-
fected cells dying by apoptosis. The involvement of apop-
tosis as the dominant PCD pathway in the presence of E.
coli was further supported by significant inhibition of
HIV-1-mediated depletion by blocking Caspase-3 activity.
Several viral proteins such as protease, gp120, Tat, Nef
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T cell death [27,28]. Enhanced HIV-1 infection following
microbial exposure could lead to increased cellular levels
of these viral proteins, thereby triggering apoptosis. Indir-
ectly, microbial products may also sensitize LP CD4+ T
cells to undergo apoptosis at a lower signaling threshold.
For example, LPS and inflammatory cytokines have been
reported to increase tryptophan catabolism by DCs [15],
potentially causing local tryptophan depletion, which then
sensitizes activated T cells to apoptosis [45,46].
Our findings in the ex vivo LPAC model have potential
implications for understanding how HIV-1 induces LP
CD4+ T cell depletion in vivo. Based on our ex vivo mod-
eling results, we theorize that mucosal pathogenesis may
proceed in two phases during early HIV-1 infection: (1)
there could be an ‘early phase’ of depletion, before intes-
tinal barrier breakdown occurs, when depletion and
inflammation are simultaneously driven by Caspase-1 me-
diated PCD in uninfected LP CD4+ T cells; and (2) a ‘late
phase’ that is driven by the onset of microbial transloca-
tion, with exposure to microbial products resulting in in-
creased HIV-1 replication and a larger role for apoptotic
death of infected LP CD4+ T cells in ongoing depletion
(Figure 7). The potential in vivo consequences of apoptotic
death of mucosal T cells could include a weakened
adaptive immunity as highlighted by other investigators
[47,48]. Corroborating this ‘biphasic model’ of early
HIV-1 mucosal pathogenesis will require directly evalu-
ating tissues from HIV-1 infected patients at varying
disease stages. Further experiments in the LPAC model,Figure 7 Biphasic model of LP CD4+ T cell death during acute HIV-1
microbial translation, pyroptotic death in bystander p24neg cells could acco
mediators released during pyroptosis may contribute to epithelial barrier b
to commensal bacteria results in enhanced HIV-1 replication, and a shift in
in particular could further exacerbate epithelial barrier dysfunction and con
death. Increased apoptotsis from productively infected cells could also con
which others have shown could reduce the potency of early adaptive imminformed by in vivo studies, should help refine mechan-
istic models of LP CD4+ T cell depletion and inflamma-
tion to ultimately provide a better understanding of
HIV-1 mucosal pathogenesis.
Conclusions
The data establish the Lamina Propria Aggregate Cul-
ture (LPAC) model as a robust and versatile platform for
studying the impact of R5-tropic HIV-1 infection and
commensal microbial species on mucosal CD4+ T cell
death. Using the LPAC model, we provide evidence for
Caspase-1 mediated T cell pyroptosis as a primary mech-
anism for LP CD4+ T cell death in bystander cells. How-
ever, upon exposure to commensal E. coli, LP CD4+ T cell
death was augmented and shifted to Caspase-3 mediated
apoptosis due to a significant increase in productively-
infected cells. The results suggest a biphasic model of LP
CD4+ T cell death during acute HIV infection, in which
distinct CD4+ T cell death pathways, demarcated by intes-
tinal barrier dysfunction and microbial translocation, may
converge to drive mucosal inflammation, viral dissemin-
ation and systemic immune activation.
Methods
Intestinal tissue samples
Macroscopically normal human jejunum tissue samples,
that would otherwise be discarded, were obtained in a
de-identified manner from 17 patients undergoing elect-
ive abdominal surgery. Those with a history of inflam-
matory bowel disease, recent chemotherapy, radiation,infection. We theorize that in ‘early’ acute infection, prior to extensive
unt for the majority of LP CD4+ T cell depletion. Inflammatory
reak down. During ‘late’ acute HIV-1 infection, T cells and APCs exposed
the LP CD4+ T cell death pathway to apoptosis. The loss of Th17 cells
tribute to a cycle of microbial entry, T cell activation, infection and
tribute to the release of apoptotic microparticles into the periphery,
une responses against HIV-1.
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the study. The use of discarded tissue was granted ex-
empt status by the Colorado Multiple Institutional Re-
view Board and patients signed a pre-operative consent
form allowing its unrestricted use.
Preparation of LPMCs from intestinal samples
The primary LP cells were obtained using a two-step frac-
tionation process as previously described [20,21]. EDTA
was used to separate the epithelial cells and intraepithelial
lymphocytes, followed by Collagenase D (Roche Catalog #:
11088882001) treatment to release the LPMCs. The cells
were cryopreserved in RPMI + 10% DMSO+ 10% FBS.
Preparation of HIV-1 stocks
MOLT4-CCR5 cells (AIDS Research and Reference Re-
agent Program; ARRP Catalog# 510) were grown at 0.5 to
1 million (M)/ml in RPMI containing 10% FBS, 1% peni-
cillin/streptomycin/glutamine and 1 mg/ml G418 (propa-
gation media) at 37°C to 50 M total cells. Majority (>90%)
of MOLT4-CCR5 cells expressed CD4 and CCR5 by flow
cytometry. 25 M MOLT4-CCR5 cells were infected with
the R5-tropic HIV-1 Ba-L strain (ARRP Catalog# 4984)
with 2 μg/ml polybrene for 2 h. The cells were washed
with propagation media and grown at 0.5 to 1 M cells/ml.
Supernatants containing virus were collected at 9 dpi and
concentrated by ultracentrifugation at 141,000×g for
2 h. The concentration of p24 in the supernatant was
determined by HIV Gag p24 ELISA (Perkin Elmer,
Walthm, MA). Virus stocks were frozen in single use al-
iquots at −80°C.
Preparation of heat-killed Eschericia coli
E. coli stocks (ATCC #25922, Manassass, VA) were grown
as described previously [21] and kept at −80°C in single
use aliquots.
LPMC infection assay
LPMCs were thawed using a standard protocol. Briefly,
1 ml aliquots of cells were quick thawed at 37°C. The
following amounts of thaw media (90 ml RPMI + 10%
FBS + 1% penicillin/streptomycin/glutamine + 100 μl
DNAse) were added at 1 min intervals: 100 μl, 200 μl,
400 μl, 800 μl, 1.6 ml, 3.2 ml (twice). The cells were cen-
trifuged at 1500 rpm for 5 mins and then washed once
in 10 ml of thaw media. The thawed LPMCs were im-
mediately resuspended in complete RPMI (RPMI + 10%
human AB serum, 1% penicillin/streptomycin/glutam-
ine, 500 μg/ml Zosyn) without any additional growth
factors. HIV-1 (80 ng p24) per 1 M LPMCs was used to
infect primary LPMCs at 10 M/ml in complete RPMI.
LPMCs were mock infected in parallel. Infection by spi-
noculation was performed at 1200×g for 2 h at room
temperature [49]. After spinoculation, the supernatantcontaining free virus was discarded; the cell pellet was
resuspended in complete RPMI at 1 M LPMCs/ml and
then seeded in a 48-well plate. Heat-killed E. coli was
added to LPMCs at a ratio of 5 E.coli: 1 LPMC where in-
dicated. Fungizone (1.25 μg/ml) was added at 1 dpi. The
LPMCs were harvested at indicated time points.LPMC Infection in the presence of drugs
For infections in the presence of Efavirenz (ARRP Catalog
#4624), LPMCs were pre-incubated with Efavirenz (1 nM
or 10 nM) for 2 h at 37°C and infected as described above
and cultured in media containing the indicated Efavirenz
dose. A second dose of Efavirenz was added at 3 dpi. At 6
dpi, the LPMCs were collected and analyzed as described.
Inhibitors of Caspase-3 (DEVD-fmk; DEVD (Calbio-
chem)) and Caspase-1 (YVAD-cmk; YVAD (Calbiochem))
were used to inhibit PCD ex vivo in donor samples that
showed depletion at 4 dpi. The YVAD motif is predomin-
ately cleaved by Caspase-1 but does have some cross
reactivity (340-fold less affinity) with other group I cas-
pases, Caspase-4 and Caspase-5 [50]. The inhibitors were
resuspended in DMSO at 50 mM and stored at −20°C per
the manufacturer’s instructions. The dose used in primary
LPMCs was based on optimization studies to balance
maximum inhibition of the pathway with minimum tox-
icity. The 4 dpi time point was chosen so that consistent
depletion was observed but DMSO exposure was min-
imal. Following HIV-1 spinoculation (0 dpi), the inhibi-
tors were added to the appropriate wells at a 25 μM
concentration. An additional dose of each inhibitor was
added to the cultures at 2 dpi without changing the
media. At 4 dpi, LPMCs were collected for analysis.Mitogen Stimulation for Th Subset Identification
6 dpi LPMCs were collected, counted, resuspended at
1 M/ml in complete RPMI, and stimulated with 100 ng/ml
PMA (Sigma-Aldrich), 100 μg/ml Ionomycin (Sigma-
Aldrich) and 1 μg/ml Brefeldin A (Golgi Plug, BD
Biosciences) for 5 h at 37°C in 5% CO2. LPMCs capable
of making IFN-γ and IL-17 were identified by flow
cytometry [21].Antibodies for flow cytometry
Aqua Viability Dye (AqVi; Invitrogen) exclusion was used
to identify viable cells. The antibodies used for these
studies were: CD3-ECD (Beckman Coulter), CD8-APC
(BD Pharmingen), CD19-APCH7 (BD Biosciences), HIV-1
p24-PE (Beckman Coulter), IL-17-V450 (BD biosciences),
IFN-γ-AF700 (BD biosciences) and AnnexinV-Pacific Blue
(Life Technologies). Isotype controls were used to estab-
lish the gates for IL-17 (Mouse IgG1- V450, BD Biosci-
ences) and IFNγ (Mouse IgG1-AF700, BD biosciences).
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LPMCs were stained with cocktails of antibodies against
markers expressed on the cell surface for 20 minutes in
PBS + 1% BSA + 2 mM EDTA (FACS buffer) at 4°C. The
LPMCs were then incubated with AqVi per the manu-
facturer’s instructions. The LPMCs were then fixed and
permeabilized using the Invitrogen Medium A/Medium
B system [21].
The best practices protocol from eBioscience was
followed to detect AnnexinV + LPMCs in conjunction
with intracellular markers incorporating minor modifica-
tions following the AqVi step in the standard protocol.
After the LPMCs were incubated with AqVi, they were
washed once with 2 ml of 1× AnnexinV binding buffer
(BD Pharmingen). The LPMCs were resuspended in 1×
AnnexinV binding buffer at a concentration of 1-3 M
cells/ml and incubated, at room temperature for 15 min,
with 5 μL of AnnexinV. Unbound AnnexinV was washed
away using 2 ml 1× AnnexinV binding buffer. The cells
were then fixed and stained for intracellular p24 using the
Medium A/Medium B system. In optimization experi-
ments, the early apoptotic phenotype was not detectable
beyond 4 dpi. Therefore, we selected samples that consist-
ently depleted at 4 dpi to determine the phenotype of the
dying CD4+ T cells.
Fluorogenic Detection of Caspase-1 Activity
2 dpi and 6 dpi LPMCs were collected and counted using
trypan blue. The LPMCs were resuspended in 75 uL of
10 mM CaspaLux-1 substrate (Oncoimmunin) and incu-
bated for 30 mins at 37°C in 5% CO2. The LPMCs were
washed once with 1 mL of the provided FACS buffer and
surface stained as described above. The LPMCs were fixed
with 4% PFA for 15 mins at room temperature, washed
once with 2 mL of FACS buffer, and acquired in 1% PFA
on the LSRII within 60 mins.
Flow cytometric acquisition and analysis
Acquisition occurred within 24 hours for all samples
and within 2 h for samples stained with AnnexinV. All
samples were collected on an LSR II flow cytometer (BD
Biosciences) and analyzed using BD FACS DIVA version
6.1.3.
To quantify depletion, the number of viable T cells in an
HIV-1 infected well was reported as a percent of the T
cells in the mock infected control well at 4 or 6 dpi. The
LPMCs were harvested and counted using trypan blue to
determine the number of live cells in the well. However,
because the LPAC model is a mixed cell culture model,
the number of live cells counted by trypan blue does not
equate to the number of viable CD4+ T cells per well. To
determine the number of viable CD4+ T cells per well,
flow cytometry was used to determine the percentage of
the viable cells (analogous to the trypan blue count) thatwere CD3+CD8- in a tight lymphocyte gate that excluded
both cellular debris and epithelial cells. The trypan blue
count was then multiplied by the percentage of viable
CD3+CD8- T cells measured by flow cytometry. For ex-
ample, if 100,000 cells were counted by trypan blue and
40% were viable CD3+CD8- T cells by flow cytometry, we
would report out 40,000 CD4+ T cells for that well. The
same method was used to determine the number of Th1,
Th17, Th1/17, and apoptotic or necrotic CD4+ T cells.
CD4+ T cell depletion was determined in the presence
and absence of E.coli.
Statistical analysis
Statistical analysis was conducted using GraphPad Prism
version 5 for Windows (GraphPad, San Diego, CA). Non-
parametric statistics were used in these analyses.
Additional files
Additional file 1: Figure S1. LPMCs used to quantify LP CD4+ T cell
survival following HIV-1 infection were phenotyped by flow cytometry
prior to infection using the following antibodies: CD45- PerCP-cy5.5; HLA-
DR- APC-Cy7; CD11c- PE-Cy5; BDCA-1- APC; CD3-ECD; CD4- AF700; CD8-
PE; gdTCR- FITC; and AquaDye Viabilty dye (AqVi) (Invitrogen). Immune
cell subsets were identified from within the CD45+ AqVi- population. The
total dendritic cell population (HLA-DR+CD11c+) was divided into BDCA-1+
and BDCA-1- populations. The donors were divided into ‘depleters’ and
‘non-depleters’ as in Figure 1D. There were no significant differences
observed in the LPMC composition at baseline between donors that de-
pleted 4 dpi and donors that did not. Significance was determined using
the Wilcoxon matched-pairs signed rank test within each phenotype. In all
cases p > 0.05.
Additional file 2: Figure S2. AnnexinV binding to exposed
phosphotidylserine on the cell surface and uptake of AqVi was measured
on p24+ versus p24neg LP CD3+CD8- T cells at 4 dpi. Each symbol is a
unique donor. The horizontal line indicates the median value and the
fold-difference between median values is indicated. Statistical significance
was determined using Wilcoxon matched-paired signed rank test. *,
p = 0.02; **, p = 0.002. (A) The percentage of p24+ and p24neg cells that
have either an apoptotic (left) or necrotic (right) phenotype during HIV-1
infection ex vivo. (B) The percentage of p24+ and p24neg cells that have
either an apoptotic (left) or necrotic (right) phenotype in the presence
of E.coli.
Additional file 3: Figure S3. LPMCs were infected with HIV-1Ba-L in the
presence or absence of E.coli for 4 days. Irreversible inhibitors of Caspase-1
(YVAD) and Caspase-3 (DEVD) at 25 μM were used to block caspase
function. DMSO was used as a vehicle control. Mock infections ± inhibitors
and DMSO were established in parallel and used to set the p24 gate. (A)
The percent of p24+ cells at 4 dpi in the absence of E. coli. Each symbol is a
unique donor. The median infection frequency is shown as the horizontal
line. No significant differences were identified using a non-parametric
repeated measures ANOVA, p = 0.43. (B) The percentage of p24+ cells in
the presence of E.coli as described in panel A. Overall ANOVA, p = 0.44. Note
that E.coli exposure enhanced HIV-1 infection to a similar extent in the
presence or absence of caspase inhibitors (compare panel B to A). (C and D)
Inhibitors do not impact the total cell number in mock + E.coli conditions.
The absolute number of LP CD4+ T cells in the mock + E.coli condition in
the presence of (C) DEVD or (D) YVAD. Each donor is represented by a
unique symbol. The horizontal lines indicate the median cell number. Using
Wilcoxon matched-paired signed rank test, no significant differences were
observed in panels C and D, p > 0.05.
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